Overview
Marco Pellicciaro practices in Rome, Italy. Mr. Pellicciaro is rated as an Experienced expert by MediFind in Liver Transplant. His top areas of expertise are Breast Cancer, Breast Infection, Severe Acute Respiratory Syndrome (SARS), Mastectomy, and Liver Transplant.
His clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Liver Transplant.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMr. Pellicciaro isAdvanced. Learn about Breast Cancer.
- Breast InfectionMr. Pellicciaro isAdvanced. Learn about Breast Infection.
- MastectomyMr. Pellicciaro isAdvanced. Learn about Mastectomy.
- Severe Acute Respiratory Syndrome (SARS)Mr. Pellicciaro isAdvanced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Experienced
- Acute PainMr. Pellicciaro isExperienced. Learn about Acute Pain.
- AdenomyosisMr. Pellicciaro isExperienced. Learn about Adenomyosis.
- AppendicitisMr. Pellicciaro isExperienced. Learn about Appendicitis.
- Autosomal Dominant Polycystic Kidney DiseaseMr. Pellicciaro isExperienced. Learn about Autosomal Dominant Polycystic Kidney Disease.
- Breast Cancer in MenMr. Pellicciaro isExperienced. Learn about Breast Cancer in Men.
- COVID-19Mr. Pellicciaro isExperienced. Learn about COVID-19.